[Headlines Only] [Top Stories Only]
Categories
· Health/Science
· Lung Cancer
· Diabetes

Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients 

Jump to full article: PR Newswire, 2008-04-09
Author: SOURCE Nektar Therapeutics

Intro:

Nektar Therapeutics (Nasdaq: NKTR) announced today that it has ceased all negotiations with potential partners for its inhaled insulin programs as a result of new data analysis from ongoing clinical trials conducted by Pfizer Inc. An increase in the number of new cases of lung cancer was observed in inhaled insulin patients as compared to the control group. All new incidences of lung cancer were in patients that are former smokers.

Jump to full article »